Form 144 INSMED Inc Filed by: Flammer Martina M.D.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
BofA Securities Reiterates Buy Rating on Insmed (INSM); 'pullback overdone'
May 12, 2026 12:02 PM EDTBofA Securities analyst Jason Zemansky reiterated a Buy rating and $214.00 price target on Insmed (NASDAQ: INSM) saying the Brinsupri launch momentum is solid and the pullback in the stock is overdone.
The analyst commented, "We hosted Insmed at an investor dinner last night... More
